Biopharmaceutical Firm Suffers Damages From Intellectual Property Infringement

I have ample experience with biopharmaceuticals and the drug development process in general, as well as particular experience in intellectual property, trade secrets, and calculating damages. My background in drug development includes several years as the head of health economics worldwide for a contract research organization. In this capacity, I was tasked with adding economic endpoints to Phase III clinical trials. I was also the head of one of the firm’s offices, and in this capacity was in charge of selling clinical trial services to the metropolitan biotechnology community. During my time at the contract research organization, I became very familiar with the details of the clinical trial process. Since that time, I have provided expert testimony on a number of occasions in disputes involving aspects of the drug development process. I have testified on multiple occasions on damages in intellectual property disputes. On a number of occasions, juries have awarded my clients 8- and 9-figure damage awards based on my testimony. I have also testified on multiple occasions in the theft of trade secret disputes. In this area, I have testified on behalf of both plaintiffs and defendants. I was the principal damage witness on behalf of the plaintiff in the civil lawsuit that followed the first felony conviction under the Economic Espionage Act. On that occasion, the jury awarded $80,000,000 in damages.